pyrroles has been researched along with Esthesioneuroblastoma, Olfactory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Gu, X; Wang, L; Wang, R; Wang, Z; Wei, L; Zhang, Y; Zhao, D | 1 |
| Dieckmann, K; Elandt, K; Hutterer, M; Koperek, O; Marosi, C; Prayer, D; Preusser, M; Sohm, M | 1 |
2 other study(ies) available for pyrroles and Esthesioneuroblastoma, Olfactory
| Article | Year |
|---|---|
Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
Topics: Adult; Antineoplastic Agents; Cetuximab; ErbB Receptors; Esthesioneuroblastoma, Olfactory; Genotyping Techniques; Humans; Indoles; Magnetic Resonance Imaging; Male; Mutation; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Precision Medicine; Proto-Oncogene Proteins c-ret; Pyrroles; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Disease stabilization of progressive olfactory neuroblastoma (esthesioneuroblastoma) under treatment with sunitinib mesylate.
Topics: Aged; Antineoplastic Agents; Esthesioneuroblastoma, Olfactory; Humans; Immunohistochemistry; Indoles; Male; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Pyrroles; Salvage Therapy; Sunitinib | 2010 |